Hypercholesterolemia Blunts NO Donor-induced Late Preconditioning Against Myocardial Infarction in Conscious Rabbits
Overview
Affiliations
Although NO donors have been shown to confer late preconditioning (PC) against myocardial ischemia/reperfusion injury in healthy rabbits, it is unknown whether concurrent systemic disorders affect NO donor-induced cardioprotection. Since many patients with coronary artery disease have hypercholesterolemia (HC), we examined the effect of this condition on late PC induced by the NO donor diethylenetriamine/nitric oxide (DETA/ NO). Chronically instrumented rabbits were fed a normal diet (normocholesterolemia, NC) or a diet enriched with 1% cholesterol (HC) for 4 weeks. Plasma cholesterol levels were significantly elevated and the arterial pressure response to the endothelium-dependent vasodilator bradykinin was blunted in cholesterol diet-fed rabbits. Conscious rabbits underwent a 30-minute coronary occlusion followed by 3 days of reperfusion. When NC rabbits were pretreated with DETA/NO (0.1 mg/kg, i. v. x 4, group II, n = 7) 24 hours before the 30-minute occlusion, infarct size was reduced by 52% (29.7 +/- 3.4% versus 62.4 +/- 4.0% of the region at risk in NC controls [group I, n = 5], P < 0.05), indicating that DETA/NO induced a late PC effect against myocardial infarction. In contrast, when HC rabbits were pretreated with the same dose of DETA/NO (group IV, n = 6), infarct size was not significantly reduced (61.0 +/- 5.7% versus 68.1 +/- 4.5% of the region at risk in HC [group III, n = 5], P = NS), suggesting that DETA/NO failed to induce a delayed cardioprotective effect. These data demonstrate, for the first time, that HC blunts NO donor-induced late PC against myocardial infarction, implying that the inhibitory effects of HC on ischemia-induced and NO donor-induced late PC are caused by disruption of biochemical pathways distal to the generation of NO that triggers these adaptations.
Preclinical multi-target strategies for myocardial ischemia-reperfusion injury.
Li Y, Gao Y, Li G Front Cardiovasc Med. 2022; 9:967115.
PMID: 36072870 PMC: 9444048. DOI: 10.3389/fcvm.2022.967115.
Andreadou I, Iliodromitis E, Lazou A, Gorbe A, Giricz Z, Schulz R Br J Pharmacol. 2017; 174(12):1555-1569.
PMID: 28060997 PMC: 5446572. DOI: 10.1111/bph.13704.
Li W, Wu N, Shu W, Jia D, Jia P Exp Ther Med. 2015; 10(6):2197-2205.
PMID: 26668616 PMC: 4665727. DOI: 10.3892/etm.2015.2782.
Ma L, Kong F, Ge H, Liu J, Gong F, Xu L Sci Rep. 2014; 4:7071.
PMID: 25400168 PMC: 4233333. DOI: 10.1038/srep07071.
Landim M, Dourado P, Casella-Filho A, Chagas A, da-Luz P Braz J Med Biol Res. 2013; 46(5):454-9.
PMID: 23681289 PMC: 3854396. DOI: 10.1590/1414-431X20132595.